| Ytd | 96.44% | |
| 1y | 75.67% |
| Open | 54.52 | Prev Close | 54.65 | Low | 54.52 | High | 54.65 | Mkt Cap | 4.50B |
| Vol | 11.61M | Avg Vol | 2.29M | EPS | -1.94 | P/E | N/A | Forward P/E | -13.62 |
| Beta | -0.40 | Short Ratio | 2.33 | Inst. Own | 112.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 53.06 | 200-d Avg | 48.19 | 1yr Est | 56.50 |
AKRO News
NextCure, Inc. (NASDAQ:NXTC) ("NextCure") and Avere Therapeutics, Inc. ("Avere"), a
Bourgeon Capital Management LLC acquired a new position in shares of Akero Therapeutics, Inc. (NASDA
Corient Private Wealth LLC acquired a new stake in shares of Akero Therapeutics, Inc. (NASDAQ: AKRO)
Alkeon Capital Management LLC increased its holdings in Akero Therapeutics, Inc. (NASDAQ: AKRO) by 1
Bagsværd, Denmark and South San Francisco, CA, US, 9 December 2025 – Novo Nordisk and Akero Therapeu
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
PHILADELPHIA , Nov. 12, 2025 /PRNewswire/ -- Berger Montague PC advises shareholders of Akero Ther
Post-hoc analyses corroborate previously reported antifibrotic effects of efruxifermin observed in 9
PHILADELPHIA , Nov. 4, 2025 /PRNewswire/ -- Berger Montague PC advises shareholders of Akero Thera
PHILADELPHIA , Oct. 29, 2025 /PRNewswire/ -- Berger Montague PC advises shareholders of Akero Thera
Obesity, type 2 diabetes, and cancer continue to grow across the globe, but pharma stocks remain off
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
Novo Nordisk said on Thursday it would acquire Akero Therapeutics for up to $5.2 billion in cash, ma
Akero Therapeutics is being acquired by Novo Nordisk for up to $5.2 billion, driven by strong phase
Major U.S. equities indexes pulled back Thursday after the S&P 500 and Nasdaq set fresh all-time hig
MILWAUKEE , Oct. 9, 2025 /PRNewswire/ -- The Ademi Firm is investigating Akero (NASDAQ: AKRO) for po
Novo Nordisk said on Thursday it would buy U.S.-based Akero Therapeutics for up to $5.2 billion to a
Novo Nordisk A/S (NYSE:NVO) is down 1% to trade at $59 this morning, after news surfaced that the ph
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkabl
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday.
U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company
Tuesday saw 132 companies set new 52-week lows.
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday.
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some bi
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the co
On Friday, 68 companies reached new 52-week highs.
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral t
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tues
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Frida
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed
Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Th